Virax Biolabs Group Limit...

0.96
-0.07 (-6.80%)
At close: Apr 04, 2025, 3:57 PM

Virax Biolabs Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020
-6.74M -5.46M -1.71M -650.98K -739.46K
103.1K n/a n/a n/a n/a
1.01M 1.73M 290.36K n/a n/a
-269.56K -237.23K 2.19K 0.00 n/a
497.06K -260.6K -32.07K 1.19K 91.67K
n/a n/a n/a n/a n/a
-1.12M -216.28K 644.39K 59.61K -96.82K
-6.25M -4.18M -809.07K -590.19K -744.61K
-1.16M -178.4K n/a n/a n/a
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
-211.95K -178.4K n/a n/a n/a
-1.16M -178.4K n/a n/a n/a
-206.27K 146.25K 100K n/a n/a
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
1.85M -111.64K 193.59K 585.2K 704.64K
1.65M 13.69M 813.21K 585.2K 704.64K
-5.76M 9.33M 4.13K -4.99K -39.97K
-7.41M -4.36M -809.07K -590.19K -744.61K